Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

November 13, 2024

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

News Features

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Yael L. Maxwell

December 14, 2023

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

May 12, 2023

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

News Features

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

April 10, 2023

The Promise of AI for Improving Health Equity in Heart Failure

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

April 04, 2023

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

July 07, 2022

Reports of Sudden Deaths Among Athletes After COVID-19 Vax are ‘Misinformation’

News Features

Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’

February 14, 2022

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

October 08, 2021

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

July 20, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

January 04, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.